Summary Background The 69th World Health Assembly endorsed the global health sector
strategy on viral hepatitis to eliminate viral hepatitis as a public health threat by 2030 …

Introduction The COVID-19 pandemic has disrupted healthcare services, reducing
opportunities to conduct routine hepatitis C virus antibody screening, clinical care, and …

There is a high incidence and prevalence of hepatitis C viral infection in persons with or
without substance use disorders (SUDs) in the Middle East and North Africa (MENA) region …

Background The COVID-19 pandemic has further strengthened the need for pharmacists to
uptake non-traditional roles. Pharmacy practice in Saudi Arabia is emerging in recent years …

Chronic hepatitis B and C are among the most significant infectious diseases worldwide,
and are major risk factors for liver cirrhosis and liver cancer. In Japan, comprehensive …

Direct-acting antivirals (DAAs) revolutionized the therapeutics of chronic hepatitis C. The
emergence and transmission of HCV variants with resistance-associated substitutions …

Background. Despite substantial progress in the treatment of hepatitis C through the use of
direct‐acting antivirals which have been shown to cure the disease, complementary and …

Evan B Cunningham and colleagues1 present a systematic review and meta-analysis of
many interventions to enhance the hepatitis C virus (HCV) care cascade. This analysis …

Hepatitis poses a major global health challenge due to viral infections that lead to significant
liver inflammation and associated morbidity and mortality. Although traditional therapies …

Δηλώνω υπεύθυνα και γνωρίζοντας τις κυρώσεις του Ν. 2121/1993 περί Πνευματικής
Ιδιοκτησίας, ότι η παρούσα μεταπτυχιακή εργασία είναι εκ ολοκλήρου αποτέλεσμα δικής μου …